ARCHIVES

Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Okays Concepts Of New Cooperative Agreements For Smoking Program, Flow Cytometry For Bladder Cancer

October 28, 1983

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Clinical Trials: Institutions Invited By NSABP To Join Raloxifene Trial

July 10, 1998

NCI Contract Process Requires Eight Months, Probably Will Get Longer As Program Grows

February 8, 1974